Eli Lilly posts long-term data for eczema therapy Ebglyss
Source: SeekingAlpha
2025-03-07 10:39:29 ET
More on Almirall, S.A., Eli Lilly, etc.
- Eli Lilly and Company (LLY) TD Cowen 45th Annual Health Care Conference (Transcript)
- Eli Lilly: Load Up Before It Leaves You Behind
- Almiralll, S.A. (LBTSF) Q4 2024 Earnings Call Transcript
- Hims & Hers down as judge denies motion over end to Lilly’s Zepbound shortage
- LifeMD, Teladoc partner with LillyDirect pharmacy provider Gifthealth for Zepbound
Read the full article on Seeking Alpha
For further details see:
Eli Lilly posts long-term data for eczema therapy Ebglyss
Almirall SA
NASDAQ: LBTSF
LBTSF Trading
0.0% G/L:
$15.35 Last:
100 Volume:
$15.35 Open:
